US 2006/0140872 A1Published application

Novel signaling pathway for the production of inglammatory pain and neuropathy

AssigneeKowa Company, Ltd.

InventorsMasutaka Furue, Hiroshi Uchi, Takeshi Nakahara

Life of this patent

Estimating the term…

Abstract

This invention relates to a remedy for treating allergic contact dermatitis containing a substance having MEK inhibitory action as its effective component.

Claims12

Dependent claims

A remedy for treating allergic contact dermatitis containing a substance having MEK inhibitory action as its effective component.

Dependencies are inferred from the claim text.

Facts

Application: 10/545,085Filed 24 Feb 2004
Priority: 26 Feb 2003
Published: 29 Jun 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/277
Nitriles; Isonitriles: having a ring, e.g. verapamil
A61K 31/275
Medicinal preparations containing organic active ingredients: nitriles; Isonitriles
A61K 31/352
Having six-membered rings with one oxygen as the only ring hetero atom: condensed with carbocyclic rings, e.g. methantheline
A61K 31/353
Condensed with carbocyclic rings, e.g. methantheline: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Family

Application60/449,752Us provisional application · filed 26 Feb 2003
US 2006/0140872 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…